Syncona Portfolio Ltd
- SEC CIK
- 0001725042
- Latest filing
- Aug 6, 2026
Holdings in Q1 2023
Holdings as of Mar 31, 2023, filed May 12, 2023. Long positions only; changes compare share counts with Q4 2022.
- Positions
- 4
- 0 vs. Q4 2022
- Portfolio value
- $61.5M
- −$1.49M (−2.4%) vs. Q4 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| AUTLAutolus Therapeutics plc | SPON ADS | 21,346,829 | $39.3M | 63.9% | 00.0% | Unchanged | History |
| Achilles Therapeutics PLC00449L102 | SPONSORED ADS | 11,086,909 | $10.6M | 17.3% | 00.0% | Unchanged | – |
| Freeline Therapeutics Hldgs35655L107 | SPONSORED ADS | 21,997,620 | $10.1M | 16.4% | 00.0% | Unchanged | – |
| ADAPYAdaptimmune Therapeutics PLC | SPONDS ADR | 1,377,294 | $1.50M | 2.4% | 00.0% | Unchanged | History |